# A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With Tezepelumab

> **NCT06706817** · PHASE3 · RECRUITING · sponsor: **AstraZeneca** · enrollment: 180 (estimated)

## Conditions studied

- Chronic Rhinosinusitis With Nasal Polyps

## Interventions

- **COMBINATION_PRODUCT:** Tezepelumab

## Key facts

- **NCT ID:** NCT06706817
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-03
- **Primary completion:** 2027-01-13
- **Final completion:** 2027-01-13
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06706817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06706817, "A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With Tezepelumab". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06706817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*